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Conjoint analysis is used to measure consumer preferences for alternative  biotech 
labeling formats. The study found that consumers overwhelmingly support mandatory 
labeling of biotech foods. Results also showed that the preferred labeling format is a text 





Analysis of Food Labels for Agricultural Biotechnology 
 
Food labeling has been an important policy issue since the Nutrition Labeling and 
Education Act (NLEA) of 1990 replaced the voluntary system of labeling established by 
the U.S. Food and Drug Administration (FDA) in 1973. The act requires mandatory 
nutrition labeling for packaged food and strict regulation of nutrition content and health 
claims.  Labeling is a means of shaping consumers’ knowledge and purchasing patterns, 
as well as, altering manufacturers’ product offering and marketing practices (Caswell and 
Mojduszka, 1996). It influences product design, promotes consumer confidence, and 
contributes to the consumer’s education regarding diet and health.   
Agricultural biotechnology is a collection of scientific techniques that involves 
taking the genes from one plant or animal species and inserting them in another species to 
transfer a desired trait or characteristic.  Modern techniques include genetic engineering 
and the use of transgenic plants.  For farmers, biotechnology is a means to reduce 
production costs, enhance yields, and increase profits. Public benefits of agricultural 
biotechnology include reductions in pesticide and herbicide use, as well as enhanced 
nutritional value, flavor, and shelf life of many foods. Despite the benefits and rapid 
adoption by farmers, consumer acceptance has been controversial, as some consumer and 
special interest groups have expressed concerns over the safety and environmental effects 
of biotech foods (USDA/ERS, 1991).  This is largely due to fears that biotech foods may 
have some unforeseen health risks, as well as, unforeseen negative effects on wildlife and 
the environment.   
Consumer concerns regarding the possible negative affects of biotechnology have 
made labeling of biotech foods an important public policy issue. The FDA has adopted a 2 
voluntary labeling policy, since tests have shown that the nutritional value of biotech 
foods is not significantly different from their traditional counterparts. Proponents of this 
policy argue that mandatory labeling would unnecessarily raise health concerns about 
biotech foods, and lead to higher food prices. Critics of the policy argue that food 
produced through biotechnology should be labeled, even if the nutritional aspect of the 
food has not been altered. They argue consumers have a right to know.  This study 
examines the labeling preferences of United States consumers for biotech foods.  The 
objective of the study is to measure consumer preferences for alternate biotech labeling 
formats.  
The Current Debate 
  The theory of food labeling was articulated in the mid 1990’s by Caswell and 
Padberg (1992) and Caswell and Mojduzka (1996). Economic theory suggests that 
government regulation of food labels is justified when market failure occurs because of 
information asymmetry between consumers and food suppliers.  Caswell and Mojduzka 
(1996) argue that food products may be viewed as bundles of product characteristics that 
consumers evaluate when making buying decisions.  Food characteristics can be 
classified as search attributes, experience attributes, or credence attributes.  Search 
attributes are characteristics that consumers can easily inspect or research prior to 
purchase, e.g. price, diversity of goods supplied, color, and some quality characteristics.  
Experience attributes can be evaluated only after purchase, such as flavor and cooking 
characteristics.  Food safety characteristics may also be experience attributes, but food-
borne illnesses are often difficult to trace back to a specific food or food-borne pathogen.  
Credence attributes are attributes that consumers cannot easily identify or inspect prior to, 3 
or after purchase.  These include most food safety attributes, as well as process-oriented 
attributes such as how a crop is grown, how food is processed, and whether 
biotechnology was used in the production of food ingredients.  Much of the debate over 
the labeling of biotech foods is couched in terms of the consumer’s right to full disclosure 
of the biotech ingredients, balanced by the government’s role in regulating the amount 
and type of information supplied to consumers, and the cost of supplying this 
information. 
  The right to full disclosure is the basis for the European Union’s mandatory 
labeling policy.  As discussed by Isaac and Phillips (2000), consumers are concerned 
about the long-term impacts on human health, environmental biodiversity, as well as the 
moral, ethical, and religious implication of biotechnology. Voluntary labeling means that 
consumer’s are not given the choice to avoid biotechnology if they wish to. Even if food 
suppliers chose to label some products “GMO free”, consumers would not know whether 
products without this label contained GMO ingredients or not.  Lack of a mandatory 
labeling policy means consumers have no way to know if their food contains biotech 
ingredients.   
On the other hand, Caswell (2000) argues there are several practical and 
economic reasons for not requiring all information to be disclosed on food labels.  For 
example, the present status of the global supply chain for food makes it virtually 
impossible to ensure that GMO ingredients are not commingled with non-GMO 
ingredients (Isaac and Phillips, 2000).  The cost of assuring the segregation of GMO and 
non-GMO ingredients would be large, and this cost would be passed on to consumers in 
the form of higher food prices. Moreover, there is a limit to the amount of information 4 
that can be realistically displayed on a label, as well as, limits on the desire and ability of 
consumers to make use of this information.    
The current U.S. policy is based on the rational that the consumer’s right to know 
should be mitigated by the fact that scientific testing shows biotech foods are 
nutritionally the same as their traditional counterparts.  Therefore, they pose no greater 
health risks than any other food.  If biotech foods are determined to be nutritionally 
different from their traditional counterparts, then mandatory labeling is required.  
Otherwise, mandatory labeling would unnecessarily raise the health concerns of 
consumers, would be costly implement, and would lead to higher labeling costs, and 
therefore higher food prices. The U.S. policy provides for voluntary labeling of food 
products that contain no biotech ingredients, given that a disclaimer is added noting the 
government’s judgment about any differences between foods that use or do not use 
GMOs (Caswell, 1998).  
Literature Review 
Several studies have examined the linkages between the consumer’s knowledge of 
biotechnology and the perceived health risks associated with biotech foods.  Grobe et al. 
(1996), conducted a national survey to analyze consumers’ risk perceptions of 
recombinant bovine growth hormone, (rbGH). A multinomial logit model was used to 
analyze how respondents’ risk perceptions are affected by their knowledge of rbGH, as 
well as  differences in their personal health risks and other socioeconomic and 
demographic variables. The study found that consumers with similar information 
displayed varying levels of risk perception. Consumers who were unaware of rbGH’s use, 
but were provided the same brief description of rbGH as more informed respondents, still 5 
exhibited diverse risk perceptions that ranged from believing the product was safe to 
perceiving personal susceptibility.  
Hoban and Kendal (1992) analyzed consumers’ perception about food safety and 
biotechnology in developed countries such as the United States, Australia, United 
Kingdom and Japan. Telephone surveys were conducted in both Japan and the United 
States from 1995 to 1998. Results indicated that an increasing number of consumers were 
willing to purchase genetically modified food products. In Australia, a national 
government survey of 1,378 people showed that 89% of respondents said that genetically 
engineered tomatoes should be labeled so that people could decide whether they wanted 
to eat these tomatoes or not. Only 4% percent were against labeling. About 65% percent 
said that labeling engineered tomatoes would be a good idea, while 65% percent said that 
unlabeled engineered tomato would be a bad idea (www. consumersinternational.org/ 
campaigns/surveys.html)  
Previous studies have indicated that consumers desire labels to indicate the 
presence of genetically modified ingredients (Huffman et al., 2001). One study relating to 
the labeling of GE foods was conducted by the Wirthlin Group Quorum Survey. 
Approximately 1000 telephone interviews were conducted in March 1997, February 
1999, and October 1999. When asked how informed they are about biotechnology, less 
than 20 percent of consumers felt they were very well informed about the technology. 
The study found that on average, 78% of Americans support the current FDA labeling 
policy for biotech foods. The present policy of the FDA is that labeling of biotech foods 
should be voluntary, since it has been determined these foods have the same safety and 
nutritional contents as other foods.  According to the study, consumers were still likely to 6 
agree with the labeling position of the FDA’s even after they were told of the mandatory 
labeling policy as argued by critics of the FDA.  Critics of the policy say that any food 
produced through biotechnology should be labeled, even if the safety aspect of the food 
has not been altered.  
According to Hallman et al., (1995), 84% of the 604 residents surveyed wanted 
mandatory labeling on engineered fruits and vegetables. Sixty percent of the population 
would consider buying fresh vegetables if they were labeled as having been produced by 
genetic engineering. Also, 58% would not specifically look for biotech labels while 
shopping.   Forty-two percent of the people who said they would look for produce labeled 
as not genetically engineered, also said they would buy produce that was genetically 
engineered if the label gave this information. Other studies by Hoban and Kendall (1992), 
Maki (1995), Douthitt (1990), and Novartis (1997) found that most Americans want 
foods that are genetically modified to be clearly identified with labels.  
Methods 
  Conjoint analysis (CA) is widely used in market research because it allows for a 
consumer’s total utility for a multidimensional product to be decomposed into 
combinations of part-worth utilities for each attribute of the product.  CA is useful 
because it provides a technique for measuring and evaluating the relative importance of 
the individual characteristics of a product. Numerous studies have used conjoint analysis 
to examine consumer or buyer preferences (Holland and Wessels, 1998; Harrison, 
Özayan, and Meyers; 1998; Huang and Fu, 1995; Halbrendt, Wirth, and Vaughn, 1991; 
Anderson and Bettencourt, 1993). The present study applies conjoint analysis to the 
biotech labeling issue.  CA is used to determine consumer preferences for alternative 
labeling formats. The steps involved in a conjoint study include identification of relevant 
product attributes and their respective levels, selection of an experimental design and 7 
survey instrument, and estimation of consumer part-worth utilities.  Each step is 
discussed in this section of the paper. 
Selection of Product Attributes 
 
A focused group discussion is frequently used for  identifying and refining 
attribute levels in a CA studies. The focus group for this study was conducted on October 
17, 2001. Five women and one man from the Baton Rouge area were recruited randomly 
from the phone book. The purpose of the focus group was to, (1) obtain information 
regarding the consumers’ general knowledge about biotechnology, and to (2) identify 
labeling attributes that are most likely to contribute to the consumer’s preferences and 
understanding of  biotech foods. Participants were asked to briefly describe what they 
knew about biotechnology. The moderator then guided them through a discussion about 
biotechnology and labeling issues in general. Handouts with information on 
biotechnology were distributed to each participant.  Information included (a) a scientific 
definition of biotechnology, (b) examples of food that contained genetically modified 
ingredients, (c) agencies that are responsible for food labeling and food label 
requirements in the U.S., and (d) information provided by food labels. The second part of 
the focus group focused on labeling of products using biotechnology. Participants were 
presented with twelve different examples of biotech food labeling. The labels differed in 
terms of (1) the use of a biotech logo, (2) text disclosure of biotech ingredients, (3) 
information about  government  agencies  that inspect and approve food products for 
human consumption. Participants were asked to rank labeling formats that ranged from a 
simple text disclosure to a “GMO Free” logo.  Results of the focus group suggested that 
participants ranked short and  simple text disclosures the highest, e.g., “this product 8 
contains ingredients produced through biotechnology”.  Text disclosures that contained 
beneficial information were also ranked highly by focus group participates, e.g.  “this 
product contains soybean oil developed using biotechnology to decrease the amount of 
saturated fat”.   A biotech logo was also included in the pre-tests.  Labels with only a logo 
were ranked lower than text disclosure, but some respondents indicated that a logo on the 
primary display panel with text disclosure on the information panel was desirable.  The 
“GMO Free” label did not rank high among the focus group participants. Based on these 
results, the attributes and attribute-levels selected for this study are presented in table 1. 
As illustrated in the table, the study calls for a 3X2X2 factorial design. A full factorial 
experimental design would involve 12 hypothetical labeling formats.  Most subjects have 
difficulty rating more than 10 product profiles, so a fractional factorial design was used to 
reduce the number of  profiles to  7 attribute-level  combinations. The Bretton-Clark 
Designer (1988) program was used to select the sample.  This program minimizes the 
confounding of attribute main effects by selecting a sub sample of orthogonal product 
combinations.   
The Survey 
A questionnaire was developed that  included questions on mandatory  versus 
voluntary labeling preferences; a conjoint experimental design on labeling formats; 
questions on the purchasing patterns of biotech foods; questions regarding the 
consumer’s use of food labels; and, questions on consumer demographics.   
  The first part of the questionnaire provided background information on 
biotechnology. It included a definition, the present and future uses (benefits), and 
examples of present applications of the technology. This was followed by  several 9 
questions regarding the respondent’s general knowledge of, and their attitudes toward 
biotechnology.  Following this introductory section, respondents were asked to choose 
between a mandatory labeling  and a voluntary labeling policy for biotech foods. A 
second question asked respondents to choose the minimum  percentage of genetically 
modified ingredients necessary for a product to be labeled.  The final set of questions 
collected information regarding the demographic and socio-economic characteristics of 
the respondent, e.g., age, income, marital status and education.  
The conjoint section of the questionnaire was a two-page layout of 7 hypothetical 
biotech label formats as prescribed by previously described  fractional design. 
Respondents were asked to rate each example of a product with a biotech label. The 
instructions required respondents to rate each example (product profile) on a scale from 0 
(least preferred) to 10 (most preferred). Ties were allowed. The survey was administered 
by mail during the month of July 2002. Dillman’s total design method was used to 
administer the survey.  Three thousand four hundred and fifty (3450) surveys were 
mailed to randomly selected household individuals in Denver, Chicago, Atlanta, Los 
Angeles, New Orleans, New York, and Houston. Responses were received from 524 (15 
% of sample) respondents. However, not all of the returned surveys were completed. 
Only 509 respondents returned a completed questionnaire for a 14.75 % useable response 
rate.  
The Model 
  As  described in the previous section, r espondents were presented with 7 
hypothetical labeling formats and were asked to rate each using a interval rating scale 
from 0 to 10. The label formats had three attributes; (1) use of biotech logo with three 10 
levels, (2) location of the biotech logo on the package with two level, and (3) the text 
disclosure of biotech ingredients with two levels. An ordered probit model is used to 
estimate consumer preferences for the labeling attributes. Conjoint measurement assumes 
a consumer’s total utility for a particular combination of attributes is a linear function of 
part-worth effects. The structural equation for the model is specified as follows: 
, i X * Ui e b + =  
where Ui* is a latent variable representing the ith individual’s total utility for a particular 
combination of label attributes; ß is a row vector of part-worth  utility  effects and the 
effects associated with selected demographic variables; X is a matrix containing dummy 
variables that  identify the selected attribute-levels for alternate labeling formats, and 
dummy variables that indicate  socioeconomic/demographic information; and  ei  is the 
error term. The OP model assumes U* is censored, with the following relationship to the 
observed dependent variable (denoted Ri): 
Ri = 0, if U*i £ 0; 
Ri = 1, if 0 < U*i £ µ 1;  




Ri = 10, if  µ9  £ U*i, 
   
where Ri is the respondent’s rating (0-10 scale) of the ith labeling format, and the m’s are 
unknown threshold parameters, which are estimated along with other model parameters. 
The OP model assumes gi is normally distributed with zero mean and variance equal to 
one.  This restriction is necessary because all values of U* are assumed to be censored in 
the OP model (Long, 1997). 11 
The dummy variable coding for the X matrix is defined as follows: X1= 1, X2 = 
0, if the text disclosure reads “this product contains soybean oil developed using 
biotechnology to decrease the amount of saturated;” X1= 0, X2= 1 if the text disclosure 
reads “this product contains ingredients derived using biotechnology;” and, X1= -1, X2 = 
-1 if no text disclosure is present. The logo’s location attribute is coded as follows; X3 = 
1 if the logo appears on the primary display panel (PDP); X3 = -1 if the biotech logo 
appears on the information panel (IP); and, X4= 1 if a logo is present and X4= -1 if no 
logo is present.  
The coding for the socioeconomic/demographic variables are defined as follows: 
EDUij = 1 if  the ith  respondent’s education level falls in the  jth of six education 
categories, zero otherwise; INCij = 1 if the ith respondent’s income falls in the jth of nine 
income categories, zero otherwise; ETHij = 1 if the ith respondent indicated their ethnic 
origins corresponds to the jth of six ethnic categories, zero otherwise; AGEij = 1 if ith 
respondent’s age corresponds to the jth of six age groups, zero otherwise; and, GENij = 1 
if the ith respondent is male, zero otherwise. 
Results 
Frequency distributions regarding respondents’ agreement or disagreement with a 
voluntary versus mandatory labeling policy are also presented in table 2. Of the 509 
respondents, 80% of the sample were in favor of a mandatory labeling policy for biotech 
foods. Only 20% of the respondents indicated they agreed with FDA’s voluntary labeling 
policy, despite being informed of FDA’s conclusion that biotech foods carry no greater 
health risks than non-biotech foods, and the concern that mandatory labeling would 
unnecessarily raise heath concerns among consumers. 12 
Frequency distributions of the socioeconomic/demographic composition of the 
sample is presented in table 3. Of the 509 respondents, 274 or (54%) were men and 235 
(46%) were women. All age groups were represented in the sample, with the 45-54 age 
group accounting for most responses, approximately 27% of sample. The median age of 
the sample was between 45 to 54 years of age. Most of the respondents were also well 
educated, as over three quarters of the sample (80%) completed some college courses, 
graduated with a bachelor degree, or had done post graduate work. The median annual 
income of respondents was between $30,000-$44,999, which accounted for about 20% of 
the sample. Six percent had annual income of less than $15,000, and 10% of respondents 
made in excess of $120,000 in yearly earnings. 
Results of the ordered probit model are presented in table 4. The chi-square 
statistic indicates that the overall model is significant at a = .001 level of confidence.  All 
part-worth estimates are  also significant at the a = .001 level of confidence. The 
relatively large positive coefficient (0.575, table 4) for the disclosure attribute that reads 
“this product contains soybean oil developed using biotechnology to decrease the amount 
of saturated fat” suggests that consumers prefer disclosures describing the benefits of 
biotechnology.  The negative sign on the “simple disclosure” statement suggests that 
consumers desire for labeling decreases even when biotech ingredients are revealed. This 
implies a clear preference for labeling only if the beneficial aspects of biotechnology are 
also revealed on the label. The relatively large negative coefficient associated with an 
absence of text disclosure is consistent with the finding that most respondents preferred 
mandatory labeling. The coefficient indicating a presence of a biotech tech logo had the 
second largest positive coefficient (0.56, table 4). In implies that the presence of a biotech 13 
logo increases the average consumer’s overall preference for biotech labeling.  The 
location of the logo had the lowest effect on respondents’ utility. However, when the logo 
appears on the Principal Display Panel (PDP), as opposed to the Informational Panel (IP), 
the average consumer’s preference for labeling increased as indicated by the positive 
0.12. 
To control for differences in respondent characteristics on labeling preferences, 
socioeconomic and demographic variables were also included in the model. These 
included age, education, income, gender, and ethnicity. Most coefficients associated with 
education are not significant. However, respondents having a bachelor degree were 
significantly different from the post graduate category (the omitted category) at the s = 
.10 level.  This provides some evidence support the hypothesis that less educated 
individuals have a greater preferences for biotech labels, compared to respondents with 
the most highly educated consumer.  The coefficient for the 55 to 65, and  65 or greater, 
age categories are positive and significant at the s = .10 or higher level. This suggest that 
respondents older than 55 years of age have a greater preference for biotech labeling 
relative to the omitted age group (45-54).  Most of the income dummy variables are not 
significant. However, the $15,000 - $29,000 group, and the more than $120,000 group, 
coefficients are negative and significant at the 5% or better level. This implies that 
respondents in these categories have a less preference for biotech labeling relative to the 
omitted category of $30,000 to $44,999. In regard to ethnic background, all estimated 
coefficients are not significant except for whites, which was negative and significant at 
the s = .10 level. This suggests that Asians (the omitted category) are more likely to 
prefer labeling of food products produced from biotechnology relative to whites.  The 14 
gender coefficient was not significantly different form zero, indicating that men and 
women have similar preference regarding biotech labels. 
The relative importance of product attributes was also calculated using the part-
worth estimates from the ordered probit model. To determine the relative importance of 
an attribute, each attribute’s highest and lowest part-worth utilities are utilized. The 
difference between the highest and lowest part-worth values establishes the utility range 
for the given attribute. Once the utility range for all attributes is determined, the relative 
importance of each attribute is calculated by dividing the utility range for the attribute by 
the sum of all attributes (Harrison et al., 1998). The equation used is,  
 
where RII is the relative importance for the ith attribute. The results indicate the most 
important attribute was the presence of a logo, contributing 48.7 % to the preference 
rating. The  type of  text disclosure was determined to be the second most relevant 
attribute, accounting for 40.87% of the preference rating. The third most important 
attribute, contributing 10.43%, was the location of the logo on the product package. 
Conclusions 
This study examined the labeling preferences of United States consumers for 
biotech foods.  The objective was to measure consumer preferences for alternate labeling 
formats for biotech foods. Conjoint analysis was used to measure consumer preferences 
for alternative labeling formats. A national survey was administered to collect the 
conjoint data, and an ordered probit model was used to estimate part-worth values for 
selected biotech labeling attributes.  
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The most significant finding of the study is that consumers overwhelmingly 
support mandatory labeling of biotech foods. Moreover, conjoint analysis showed that the 
preferred format is an information label with a text disclosure that describes the benefits 
of biotechnology in combination with a biotech logo located on the primary display panel 
of the package. This implies that any educational effort (mandatory or voluntary) should 
focus on the informing consumer of the beneficial aspects of biotech food products.  
One limitation of the study is that only the 7 largest metropolitan regions of the 
United States were surveyed.  The preferences of individuals from rural areas of the 
United States may differ from those found among urban consumers. Another limitation of 
the study was that most respondents had either some college, or higher levels of 
education, thus results presented here should be interpreted with this in mind. Future 
research could focus on sampling a more diverse group of consumers. Future research 
could also focus on measuring consumers’ willingness to pay for biotech labels.  
 16 
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Table 1 Attributes and Their Levels Used in Survey 
Attribute  Levels 
Insert in the ingredients section of information 
panel reads: “This product contains ingredients 
derived using biotechnology.” 
Insert in the ingredients section of information 
panel reads: “This product contains soybean oil 
developed using biotechnology to decrease the 
amount of saturated fat.” 
Text disclosure of biotech  
Ingredients 
No text Disclosure 
Present  Biotech logo 
Absent 
Principal Display Panel  Location of a Biotech logo 
Informational Panel 
Table 2.  Respondent’s Responses to a Mandatory or Voluntary Labeling Policy 
  Number of Respondents  Percentage of Respondents 
Voluntary Labeling  103  20 
Mandatory Labeling  406  80 
 19 
Table 3.  Frequency Distribution of Socio-Demographic Characteristics of Respondents 
for Biotech Labeling Survey 
Demographic Characteristics 
     Sample (n= 509) 
Number  Percentage 
Gender                        
Male   274  54.0 
Female  235  46.0 
     
Age (years)     
18-24   12  2.36 
25-34  56  11.00 
35-44  99  19.45 
45-54  135  26.52 
55-65  93  18.27 
65 or older  114  22.40 
     
Education     
Less than high school  2  0.39 
Completed High school  58  11.39 
Technical school  37  7.27 
Some college  119  23.88 
Completed bachelor degree   150  29.47 
Post graduate work  143  28.09 
     
Income     
Less than $15,000  33  6.48 
$15,000 -$29,000  47  9.23 
$30,000 - $44,999  101  19.84 
$45,000 - $59,999  99  19.45 
$60,000 -$74,999   76  14.93 
$75,000 -$89,999  53  10.41 
$90,000 -$104,999  32  6.29 
$105,000 -$119,999  19  3.73 
More than $120,000  49  9.63 
 20 
Table 4. Ordered Probit Part Worth Estimates for Conjoint Analysis of Biotech  Labeling 
Formats in Combination with Demographic 
Variable  Coefficient   Standard 
Error 
(t-ratio)  P-Value 
 
Label Attributes 
       
Constant  1.207***  0.151  7.961  0.000 
Text disclosure that describes the benefits 
of biotech ingredients  
0.575***  0.037  15.255  0.000 
Simple biotech text disclosure  -0.218***  0.039  -5.522  0.000 
No Text   -0.357***  0.049  -7.262  0.000 
Biotech logo appears on the PDP  0.122***  0.030  4.029  0.001 
Presence or absence of a biotech logo  0.557***  0.033  17.074  0.000 
Gender
a         
Female      0.012  0.051  0.241  0.809 
Education
b         
Completed high school      0.083  0.097  0.856  0.392 
Technical college      0.042  0.099  0.422  0.673 
Some college      0.064  0.073  0.886  0.376 




       
Less than 15,000     -0.191       0.127  -1.510  0.131 
$15,000 - $29,999    -0.258***  0.094  -2.746  0.006 
$45,000 - $59,999    -0.244***  0.081  -3.019  0.003 
$60,000 -$74,999     -0.121  0.088  -1.383  0.167 
$75,000 -$89,999    -0.041  0.094  -0.441  0.659 
$90,000 -$104,999    -0.074  0.113  -0.657  0.511 
$105,000 -$119,999    -0.014  0.133  -0.104  0.917 
More than $120,000    -0.282**  0.119  -2.364  0.018 
Age
d         
18-24      0.135       0.161  0.834  0.405 
25-34     0.026  0.096  0.271  0.786 
35-44     0.101  0.075  1.396  0.163 
55-65     0.124*  0.069  1.813  0.069 
65 or older     0.172**  0.078  2.197  0.028 
Ethnic Origin
e         
White     -0.229*  0.132  -1.743  0.081 
African American    -0.255  0.176  -1.447  0.148 
American Indian    -0.139  0.394  -0.353  0.724 
Hispanic    -0.237  0.167  -1.415  0.157 
Other    -0.203  0.180  -1.125  0.260 
***, **,*, Indicates estimated coefficient is significant at the .01,.05,and .10 level, respectively 
 c
2 Log-L -4150.94 ; Chi-square = 777.28; N= 3,563;
 a Excludes the gender male.
 b Excludes the post 
graduate work category. 
c Excludes the $30,000 - $44,999 income category;
 d Excludes the 45 –54 age 
group category. 
e Excludes the Asian category. 